168 related articles for article (PubMed ID: 3416024)
41. Can nicotine self-inhibition account for its low efficacy at the nicotinic acetylcholine receptor from Torpedo?
Tonner PH; Wood SC; Miller KW
Mol Pharmacol; 1992 Nov; 42(5):890-7. PubMed ID: 1279379
[TBL] [Abstract][Full Text] [Related]
42. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
Ochoa EL; Li LA; Plummer A; McNamee MG
Mol Pharmacol; 1990 Dec; 38(6):863-71. PubMed ID: 2250665
[TBL] [Abstract][Full Text] [Related]
43. Multiple actions of substance P that regulate the functional properties of acetylcholine receptors of clonal rat PC12 cells.
Boyd ND; Leeman SE
J Physiol; 1987 Aug; 389():69-97. PubMed ID: 2445982
[TBL] [Abstract][Full Text] [Related]
44. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.
Swanson KL; Allen CN; Aronstam RS; Rapoport H; Albuquerque EX
Mol Pharmacol; 1986 Mar; 29(3):250-7. PubMed ID: 2419745
[TBL] [Abstract][Full Text] [Related]
45. Three-dimensional structure of the nicotinic acetylcholine receptor and location of the major associated 43-kD cytoskeletal protein, determined at 22 A by low dose electron microscopy and x-ray diffraction to 12.5 A.
Mitra AK; McCarthy MP; Stroud RM
J Cell Biol; 1989 Aug; 109(2):755-74. PubMed ID: 2760111
[TBL] [Abstract][Full Text] [Related]
46. Isoflurane increases the apparent agonist affinity of the nicotinic acetylcholine receptor.
Raines DE; Zachariah VT
Anesthesiology; 1999 Jan; 90(1):135-46. PubMed ID: 9915322
[TBL] [Abstract][Full Text] [Related]
47. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
48. Calcium-dependent effect of the thymic polypeptide thymopoietin on the desensitization of the nicotinic acetylcholine receptor.
Revah F; Mulle C; Pinset C; Audhya T; Goldstein G; Changeux JP
Proc Natl Acad Sci U S A; 1987 May; 84(10):3477-81. PubMed ID: 2437580
[TBL] [Abstract][Full Text] [Related]
49. Time-resolved photolabeling by quinacrine azide of a noncompetitive inhibitor site of the nicotinic acetylcholine receptor in a transient, agonist-induced state.
Cox RN; Kaldany RR; DiPaola M; Karlin A
J Biol Chem; 1985 Jun; 260(12):7186-93. PubMed ID: 2860110
[TBL] [Abstract][Full Text] [Related]
50. Interaction of a semirigid agonist with Torpedo acetylcholine receptor.
Kawai H; Cao L; Dunn SM; Dryden WF; Raftery MA
Biochemistry; 2000 Apr; 39(14):3867-76. PubMed ID: 10747774
[TBL] [Abstract][Full Text] [Related]
51. Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin.
Eldefrawi ME; Aronstam RS; Bakry NM; Eldefrawi AT; Albuquerque EX
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2309-13. PubMed ID: 6246539
[TBL] [Abstract][Full Text] [Related]
52. General anesthetics modify the kinetics of nicotinic acetylcholine receptor desensitization at clinically relevant concentrations.
Raines DE; Rankin SE; Miller KW
Anesthesiology; 1995 Jan; 82(1):276-87; discussion 31A-32A. PubMed ID: 7832311
[TBL] [Abstract][Full Text] [Related]
53. The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.
Olivera-Bravo S; Ivorra I; Morales A
Br J Pharmacol; 2005 Jan; 144(1):88-97. PubMed ID: 15644872
[TBL] [Abstract][Full Text] [Related]
54. Activation of Torpedo acetylcholine receptors expressed in mouse fibroblasts. Single channel current kinetics reveal distinct agonist binding affinities.
Sine SM; Claudio T; Sigworth FJ
J Gen Physiol; 1990 Aug; 96(2):395-437. PubMed ID: 1698917
[TBL] [Abstract][Full Text] [Related]
55. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
Dodson BA; Braswell LM; Miller KW
Mol Pharmacol; 1987 Jul; 32(1):119-26. PubMed ID: 3600612
[TBL] [Abstract][Full Text] [Related]
56. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
Marinou M; Tzartos SJ
Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
[TBL] [Abstract][Full Text] [Related]
57. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities.
Katz EJ; Cortes VI; Eldefrawi ME; Eldefrawi AT
Toxicol Appl Pharmacol; 1997 Oct; 146(2):227-36. PubMed ID: 9344890
[TBL] [Abstract][Full Text] [Related]
58. Kinetics of agonist-induced intrinsic fluorescence changes in the Torpedo acetylcholine receptor.
Kawai H; Raftery MA
J Biochem; 2010 May; 147(5):743-9. PubMed ID: 20123701
[TBL] [Abstract][Full Text] [Related]
59. Site-selective agonist binding to the nicotinic acetylcholine receptor from Torpedo californica.
Song XZ; Andreeva IE; Pedersen SE
Biochemistry; 2003 Apr; 42(14):4197-207. PubMed ID: 12680774
[TBL] [Abstract][Full Text] [Related]
60. The cholesterol dependence of activation and fast desensitization of the nicotinic acetylcholine receptor.
Rankin SE; Addona GH; Kloczewiak MA; Bugge B; Miller KW
Biophys J; 1997 Nov; 73(5):2446-55. PubMed ID: 9370438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
